Heat shock protein 60: An endogenous inducer of dopaminergic cell death in Parkinson disease

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Noelker, Carmen ^a,b   Morel, Lydie ^a   Osterloh, Anke ^c   Alvarez Fischer, Daniel ^a,b,d   Lescot, Thomas ^a   Breloer, Minka ^c   Gold, Maike ^b   Oertel, Wolfgang H ^b   Henze, Carmen ^a   Michel, Patrick P ^a   Dodel, Richard C ^b   Lu, Lixia ^a   Hirsch, Etienne C ^a   Hunot, Stéphane ^a   Hartmann, Andreas ^a  

^a INSERM   (France)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Hsp60; Innate immunity; Microglia; Neurodegeneration; Neuroinflammation; PD

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHAPERONIN 60; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; DOPAMINE RECEPTOR STIMULATING AGENT; PROTEIN BINDING; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL LYSATE; CELL STRESS; CONTROLLED STUDY; CORPUS STRIATUM; CYTOKINE PRODUCTION; DOPAMINERGIC SYSTEM; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; MALE; MESENCEPHALON; MICROGLIAL CELL CULTURE; MOUSE; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PROTEIN SECRETION; SUBSTANTIA NIGRA; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; GENETICS; INTOXICATION; METABOLISM; MICROGLIA; PATHOLOGY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CELL DEATH; CELLS, CULTURED; CHAPERONIN 60; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; DOPAMINERGIC NEURONS; L-LACTATE DEHYDROGENASE; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICROGLIA; MPTP POISONING; NITRIC OXIDE; PROTEIN BINDING; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 84899999860     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-86     Document Type: Article

References (57)

1. Fahn SPS. Parkinsonism. Meritt's Neurology 2000, 679-693. New York: Lippincott, Rowland LP, 10.
2. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol 2009, 8:382-397. 10.1016/S1474-4422(09)70062-6, 19296921.
3. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291. 10.1212/WNL.38.8.1285, 3399080.
4. Barcia C, Sanchez Bahillo A, Fernandez-Villalba E, Bautista V, Poza YPM, Fernandez-Barreiro A, Hirsch EC, Herrero MT. Evidence of active microglia in substantia nigra pars compacta of Parkinsonian monkeys 1 year after MPTP exposure. Glia 2004, 46:402-409. 10.1002/glia.20015, 15095370.
5. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 1999, 46:598-605. 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F, 10514096.
6. McGeer PL, Schwab C, Parent A, Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol 2003, 54:599-604. 10.1002/ana.10728, 14595649.
7. Laflamme N, Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. Faseb J 2001, 15:155-163. 10.1096/fj.00-0339com, 11149903.
8. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005, 17:338-344. 10.1016/j.coi.2005.02.007, 15950447.
9. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004, 76:514-519. 10.1189/jlb.0304127, 15178705.
10. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J Leukoc Biol 2010, 87:989-999. 10.1189/jlb.1209775, 20179153.
11. Sharp FR, Massa SM, Swanson RA. Heat-shock protein protection. Trends Neurosci 1999, 22:97-99. 10.1016/S0166-2236(98)01392-7, 10199631.
12. Barreto A, Gonzalez JM, Kabingu E, Asea A, Fiorentino S. Stress-induced release of HSC70 from human tumors. Cell Immunol 2003, 222:97-104. 10.1016/S0008-8749(03)00115-1, 12826079.
13. Lang A, Benke D, Eitner F, Engel D, Ehrlich S, Breloer M, Hamilton-Williams E, Specht S, Hoerauf A, Floege J, von Bonin A, Kurts C. Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. J Am Soc Nephrol 2005, 16:383-391. 10.1681/ASN.2004040276, 15601747.
14. Rajaiah R, Moudgil KD. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 2009, 8:388-393. 10.1016/j.autrev.2008.12.004, 2668694, 19121415.
15. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 2008, 7:97-109. 10.1016/S1474-4422(07)70327-7, 18093566.
16. Pfister G, Stroh CM, Perschinka H, Kind M, Knoflach M, Hinterdorfer P, Wick G. Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J Cell Sci 2005, 118:1587-1594. 10.1242/jcs.02292, 15784682.
17. Sapozhnikov AM, Ponomarev ED, Tarasenko TN, Telford WG. Spontaneous apoptosis and expression of cell surface heat-shock proteins in cultured EL-4 lymphoma cells. Cell Prolif 1999, 32:363-378. 10.1111/j.1365-2184.1999.tb01354.x, 10646688.
18. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000, 164:558-561. 10.4049/jimmunol.164.2.558, 10623794.
19. Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, Nitsch R, Weber JR. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 2008, 28:2320-2331. 10.1523/JNEUROSCI.4760-07.2008, 18322079.
20. Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2007, 2:141-151. 10.1038/nprot.2006.342, 17401348.
21. Sonsalla PK, Heikkila RE. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur J Pharmacol 1986, 129:339-345. 10.1016/0014-2999(86)90444-9, 3490988.
22. Tanaka T, Iqbal K, Trenkner E, Liu DJ, Grundke-Iqbal I. Abnormally phosphorylated tau in SY5Y human neuroblastoma cells. FEBS Lett 1995, 360:5-9. 10.1016/0014-5793(95)00061-D, 7875300.
23. Gomez C, Reiriz J, Pique M, Gil J, Ferrer I, Ambrosio S. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res 2001, 63:421-428. 10.1002/1097-4547(20010301)63:5<421::AID-JNR1037>3.0.CO;2-4, 11223917.
24. Michel PP, Agid Y. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J Neurochem 1996, 67:1633-1642.
25. Salthun-Lassalle B, Hirsch EC, Wolfart J, Ruberg M, Michel PP. Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci 2004, 24:5922-5930. 10.1523/JNEUROSCI.5668-03.2004, 15229240.
26. Knusel B, Michel PP, Schwaber JS, Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J Neurosci 1990, 10:558-570.
27. Kawamoto JC, Barrett JN. Cryopreservation of primary neurons for tissue culture. Brain Res 1986, 384:84-93. 10.1016/0006-8993(86)91222-9, 3791002.
28. Mourlevat S, Troadec JD, Ruberg M, Michel PP. Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes. Mol Pharmacol 2003, 64:578-586. 10.1124/mol.64.3.578, 12920193.
29. Michel PP, Dandapani BK, Knusel B, Sanchez-Ramos J, Hefti F. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility. J Neurochem 1990, 54:1102-1109. 10.1111/j.1471-4159.1990.tb01935.x, 1968953.
30. Saura J, Tusell JM, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189. 10.1002/glia.10274, 14603460.
31. Mattson MP, Barger SW, Begley JG, Mark RJ. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol 1995, 46:187-216.
32. Van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: the MTT assay. Methods Mol Biol 2011, 731:237-245. 10.1007/978-1-61779-080-5_20, 21516412.
33. Stockert JC, Blazquez-Castro A, Canete M, Horobin RW, Villanueva A. MTT assay for cell viability: intracellular localization of the formazan product is in lipid droplets. Acta Histochem 2012, 114:785-796. 10.1016/j.acthis.2012.01.006, 22341561.
34. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145. 10.1038/35100529, 11905821.
35. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
36. Amano F, Noda T. Improved detection of nitric oxide radical (NO.) production in an activated macrophage culture with a radical scavenger, carboxy PTIO and Griess reagent. FEBS Lett 1995, 368:425-428. 10.1016/0014-5793(95)00700-J, 7543422.
37. Jang YO, Quan X, Das R, Xu S, Chung CH, Ahn CM, Baik SK, Kong ID, Park KS, Kim MY. High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells. BMC Gastroenterol 2012, 12:4. 10.1186/1471-230X-12-4, 3288815, 22230186.
38. Michel PP, Ruberg M, Agid Y. Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J Neurochem 1997, 69:1499-1507.
39. Habich C, Baumgart K, Kolb H, Burkart V. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J Immunol 2002, 168:569-576. 10.4049/jimmunol.168.2.569, 11777948.
40. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, Wagner H. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001, 276:31332-31339. 10.1074/jbc.M103217200, 11402040.
41. Osterloh A, Kalinke U, Weiss S, Fleischer B, Breloer M. Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide. J Biol Chem 2007, 282:4669-4680. 10.1074/jbc.M608666200, 17164250.
42. Welch WJ. Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells. Philos Trans R Soc Lond B Biol Sci 1993, 339:327-333. 10.1098/rstb.1993.0031, 8098537.
43. Quintana FJ, Cohen IR. The HSP60 immune system network. Trends Immunol 2011, 32:89-95. 10.1016/j.it.2010.11.001, 21145789.
44. Breloer M, Dorner B, More SH, Roderian T, Fleischer B, von Bonin A. Heat shock proteins as 'danger signals': eukaryotic Hsp60 enhances and accelerates antigen-specific IFN-gamma production in T cells. Eur J Immunol 2001, 31:2051-2059. 10.1002/1521-4141(200107)31:7<2051::AID-IMMU2051>3.0.CO;2-H, 11449358.
45. Chen W, Syldath U, Bellmann K, Burkart V, Kolb H. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 1999, 162:3212-3219.
46. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001, 13:114-119. 10.1016/S0952-7915(00)00191-6, 11154927.
47. Wallin RP, Lundqvist A, More SH, von Bonin A, Kiessling R, Ljunggren HG. Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002, 23:130-135. 10.1016/S1471-4906(01)02168-8, 11864840.
48. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 1999, 5:1403-1409. 10.1038/70978, 10581083.
49. Noelker C, Morel L, Lescot T, Osterloh A, Alvarez-Fischer D, Breloer M, Henze C, Depboylu C, Skrzydelski D, Michel PP, Dodel RC, Lu L, Hirsch EC, Hunot S, Hartmann A. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep 2013, 3:1393. 3589722, 23462811.
50. Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N. Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. Glia 2013, 61:349-360. 10.1002/glia.22437, 3568908, 23108585.
51. Jayakumar AR, Tong XY, Curtis KM, Ruiz-Cordero R, Abreu MT, Norenberg MD. Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy. J Neurochem 2014, 128:890-903. 10.1111/jnc.12516, 24261962.
52. Pascual-Lucas M, Fernandez-Lizarbe S, Montesinos J, Guerri C. LPS or ethanol triggers clathrin- and rafts/caveolae-dependent endocytosis of TLR4 in cortical astrocytes. J Neurochem 2014, 129:448-462. 10.1111/jnc.12639, 24345077.
53. Tarassishin L, Suh HS, Lee SC. LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14. Glia 2014, 62:999-1013. 10.1002/glia.22657, 24659539.
54. Flohe SB, Bruggemann J, Lendemans S, Nikulina M, Meierhoff G, Flohe S, Kolb H. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol 2003, 170:2340-2348. 10.4049/jimmunol.170.5.2340, 12594256.
55. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000, 164:13-17. 10.4049/jimmunol.164.1.13, 10604986.
56. Osterloh A, Veit A, Gessner A, Fleischer B, Breloer M. Hsp60-mediated T cell stimulation is independent of TLR4 and IL-12. Int Immunol 2008, 20:433-443. 10.1093/intimm/dxn003, 18256040.
57. Zhang D, Sun L, Zhu H, Wang L, Wu W, Xie J, Gu J. Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity. Neurochem Int 2012, 61:1021-1035. 10.1016/j.neuint.2012.07.019, 22847064.